The Vanguard Small-Cap Value ETF (VBR) offers low-cost, diversified exposure to US small-cap value stocks, tracking the CRSP US Small Cap Value Index. VBR provides a 2.07% yield, strong distribution growth, and broad sector diversification, minimizing concentration risk to any one sector or company. Compared to peers, VBR stands out for its lowest expense ratio and consistent outperformance, though it lacks significant exposure to high-growth sectors.

Block said it expects annual gross profit growth through 2028 to be in the mid-teens, with adjusted operating income climbing about 30% annually. The company also expanded its share repurchase program by $5 billion, adding to the $1.1 billion in remaining authorization as of Sept.

DISTRIBUTED-WORK-MODEL/OAKLAND, Calif.--(BUSINESS WIRE)--Block, Inc. (NYSE: XYZ) will share its three-year financial outlook during its previously announced 2025 Investor Day. The company will outline a plan for profitable growth and operating leverage over the next three years, reflecting the scale of its ecosystems, including Cash App, Square and Proto, as well as continued discipline in execution. At the event, Block will share guidance on key business performance metrics it expects over the.

Global-E Online Ltd. ( GLBE ) Q3 2025 Earnings Call November 19, 2025 8:00 AM EST Company Participants Alan Katz - Head of Investor Relations Amir Schlachet - Co-Founder, CEO & Chairman of the Board Ofer Koren - Chief Financial Officer Nir Debbi - Co-Founder, President & Director Conference Call Participants William Nance - Goldman Sachs Group, Inc., Research Division Michael Infante - Morgan Stanley, Research Division Brian Peterson - Raymond James & Associates, Inc., Research Division Mark Zgutowicz - The Benchmark Company, LLC, Research Division Patrick Walravens - Citizens JMP Securities, LLC, Research Division Koji Ikeda - BofA Securities, …

Enanta Pharmaceuticals (ENTA) remains a "Buy" due to promising secondary endpoints for zelicapavir in RSV, despite missing its primary endpoint. Company's pipeline strength is supported by EDP-323's positive prophylaxis data and robust preclinical immunology programs targeting STAT6 and KIT pathways. The company's strong cash position, now extended into fiscal 2029 after a recent equity raise, ensures continued development of its clinical programs.

Matt Maley sees a "change in trend" after the SPX and NDX closed below their 50-day SMA this week for the first time since April. He believes investors are taking froth out of the markets.

CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today announced it has acquired Blue Eye, a leading provider of AI-powered enterprise remote video monitoring (RVM) services, based in Salt Lake City, Utah. Blue Eye provides a comprehensive RVM service powered by AI to help detect threats in real time, enabling live voice talk-downs to deter crime and providing verified alerts to help accelerate law enforcement response. The company's software platform is interoperable with leading camer.

SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy. The developments and significant market reaction have prompted shareholder rights law firm Hagens Berman to open an investigation into whether Zimmer Biomet may have violated the federal securities laws.

SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Investors in multi-cloud application services provider F5, Inc. (NASDAQ: FFIV) saw the price of their shares slide $22.83 (-7.8%) on October 28, 2025 after the company reported its Q4 2025 results but provided disappointing guidance, which F5 in part attributed to a cybersecurity breach by foreign actors that it became aware of in August 2025.

SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Shareholder rights firm Hagens Berman is scrutinizing Icelandic biopharmaceutical company Alvotech (NASDAQ: ALVO) over the propriety of its disclosures regarding its lead drug candidate and its manufacturing operations, following a dramatic revision to the company's full-year financial forecasts. The firm urges investors in Alvotech who suffered significant losses to submit your losses now.

Warner Music Group (WMG) has settled a copyright infringement case with AI music startup Udio, the label announced on Wednesday. The two have also entered into a licensing deal for an AI music creation service that's set to launch in 2026.

SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against beverage company Primo Brands Corporation (NYSE: PRMB) in the wake of its troubled merger with BlueTriton Brands. The suit seeks to represent investors who purchased or otherwise acquired the common stock of Primo Water between June 17, 2024 and November 8, 2024.

The agreements are valued at a combined $800 million annually.

SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Investors in Trex Company, Inc. (NYSE: TREX) saw the price of their shares crater as much as $14.88 (-31%) during intraday trading on November 5, 2025, after the building products company reported disappointing Q3 2025 financial results and dramatically reduced expected 2025 sales growth. The developments and severe market reaction has prompted national shareholders rights firm Hagens Berman to investigate whether Trex may have misled investors about adverse trends impacting its business and whether Trex sold more products to its customers than they needed.

Protara Therapeutics, Inc. ( TARA ) Discusses Interim Results From Phase II STARBORN-1 Trial of TARA-002 in Pediatric Lymphatic Malformations November 19, 2025 8:30 AM EST Company Participants Justine O'Malley - Senior Vice President of Investor Relations & Corporate Affairs Jesse Shefferman - Co-founder, CEO, President & Director Jacqueline Zummo - Co-Founder & Chief Scientific Operations Officer William Conkling - Chief Commercial Officer Conference Call Participants Jesse Jones Li Wang Watsek - Cantor Fitzgerald & Co., Research Division Soumit Roy - JonesTrading Institutional Services, LLC, Research Division Vishwesh Shah - TD Cowen, Research Division Yue-Wen Zhu - LifeSci Capital, LLC, …

Crescent Capital BDC offers a compelling 12.6% regular dividend yield and trades at a 31% discount to book value. CCAP maintains a conservatively managed, diversified portfolio with strong dividend coverage and an improving non-accrual rate. The BDC's focus on sponsor-backed companies, solid balance sheet, and potential for increased non-interest income support its investment case.

Ameren raises its 2025 outlook and invests heavily in long-term growth with clean-energy and nuclear expansion plans.

HOUSTON and CAMBRIDGE, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) cites an error on the S&P CapIQ platform and reiterates that its common stock continues to trade uninterrupted on the Nasdaq Stock Market under the stock ticker “SLRX.

Carvana Co (NYSE:CVNA) is trading 2.3% higher at $324.67 this afternoon, attempting to extend a rebound off the $280 level, a site that captured its June pullback as well.

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE: AVTR) common stock during the period between March 5, 2024 and October 28, 2025, inclusive (the "Class Period"). The lawsuit seeks to recover losses for investors under the federal securities laws.